Catalyst Wire Dossier Catalyst Wire Dossier

OratecanTM

· Hanmi Pharmaceutical Company Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OratecanTM, covering 2011-12-07 to 2013-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) [Phase 1]

See pricing